跳至主要内容
临床试验/NCT07806266
NCT07806266招募中不适用

The European Organisation for Research and Treatment of Cancer: Module Development for Metastatic Breast Cancer (Phase I-IIIa/b)

University of Leeds22 个研究点 分布在 14 个国家目标入组 568 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
568
试验地点
22
主要终点
Quality of life of females with metastatic breast cancer

研究概览

简要总结

The overall aim of this project is to help improve the Health Related Quality of Life (HRQOL) of metastatic breast cancer (MBC) patients. There is currently an urgent and unmet need for specific tools to aid in the evaluation of HRQOL in MBC and this project aims to address these needs by developing a comprehensive EORTC questionnaire for assessing the HRQOL of this group. The new module will be used in conjunction with EORTC QLQ-C30 and will provide better measurement of the quality of life issues experienced by women with MBC. Interviews will be conducted with patients from several centres across Europe, guiding the development process in a patient centred way.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult females aged 18 years or over.
  • Have a diagnosis of MBC (Breast cancer that has spread to another part of the body), including de novo MBC patients. Patients with brain metastases will be included, providing there is no associated major cognitive impairment.
  • Have received (patients under observation) or currently receiving treatment for MBC, including chemotherapy, hormone therapy, targeted agents (anti-HER2, CDK4/6 inhibitors, mTOR/PIK3CA inhibitors, PARP inhibitors, immune therapy), radiotherapy and combinations.
  • Conversant in the language of questionnaire administration.
  • Have the capacity to give informed consent.

排除标准

  • Patients diagnosed with early stage breast cancer.
  • Patients with any psychiatric condition or cognitive impairment, as determined by the treating physician, that would hamper participation in interviews.
  • Patients previously involved in Phase I.

结局指标

主要结局

Quality of life of females with metastatic breast cancer

时间窗: 1 month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Galina Velikova

Professor Galina Velikova

University of Leeds

研究点 (22)

Loading locations...

相似试验